UBS analyst Radi Sultan lowered the firm’s price target on Confluent (CFLT) to $30 from $38 and keeps a Buy rating on the shares. Confluent shares were down following the lowered 2025 growth outlook, with the company citing macro driving an uptick in optimizations and slower use case adds in the larger customer base, the analyst tells investors in a research note. UBS argues that Confluent may be sitting in front of a real product cycle between Tableflow, Flink, and WarpStream, which could drive material incremental growth.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CFLT:
- Confluent price target lowered to $32 from $40 at Piper Sandler
- Confluent’s Strong Q1 Performance and Strategic Positioning Justify Buy Rating
- Confluent price target lowered to $32 from $38 at Canaccord
- Confluent price target lowered to $31 from $38 at Guggenheim
- Confluent’s Strong Performance and Growth Potential Justifies Buy Rating Despite Adjusted Guidance